Markets.com Logo

MGNX

$--
--%
1d
1w
1m

Analysis and statistics

  • Open
    1.478$
  • Previous Close
    1.4334$
  • 52 Week Change
    4.11$
  • Day Range
    0.04$
  • 52 Week High/Low
    0.9897$ - 5.1$
  • Dividend Per Share
    --
  • Market cap
    91 016 K$
  • EPS
    -0.57
  • Beta
    1.656
  • Volume
    --

About

MGNX.US represents the common stock of MacroGenics, Inc., a biopharmaceutical company focused on discovering and developing innovative antibody-based therapeutics for the treatment of cancer. MacroGenics utilizes its proprietary DART (Dual-Affinity Re-Targeting) platform and other technology platforms to create novel immuno-oncology and antibody-drug conjugate (ADC) product candidates. The company's pipeline includes MARGENZA (margetuximab-cmkb), an Fc-engineered monoclonal antibody approved for certain metastatic breast cancer patients, as well as other investigational therapies in clinical development.

Gold's Safe-Haven Status Under Scrutiny: Market Dynamics and Price Outlook

Emma Rose|--

Trump's Iran War Exit Without a Deal: Reshaping Middle East Energy Security and Power Dynamics

Emma Rose|--
European market insights: What is the European stock market doing right now?

European market insights: What is the European stock market doing right now?

Ghko B|--
EUR/USD Analysis Today: EUR/USD Gains to 1.1550 as Middle East Uncertainty Lingers

EUR/USD Analysis Today: EUR/USD Gains to 1.1550 as Middle East Uncertainty Lingers

Ghko B|--

Microsoft at a Crossroads: AI Hurdles and Cloud Resilience Amidst Market Volatility

Sophia Claire|--

Iran's Hormuz Gambit: Leveraging a Chokepoint for Economic Leverage and Global Impact

Ava Grace|--

Gold Market Resilience: Navigating Sell-offs and Sustaining Bull Run

Noah Lee|--

Factors

Here's a response about factors affecting MGNX.US stock price, following the requested format: Clinical Trial Results: Positive data from clinical trials for Margenza (margetuximab) or other pipeline drugs typically drives the stock price up. Conversely, negative or inconclusive results can lead to a decline.

Regulatory Approvals: Approval of Margenza for new indications or other products in the pipeline by regulatory bodies like the FDA significantly increases revenue potential and stock value. Delays or rejections can negatively impact the stock.

Sales Performance: Sales figures for Margenza directly impact revenue and profitability. Strong sales growth usually translates to increased investor confidence and a higher stock price. Weak sales can trigger a sell-off.

Partnerships and Collaborations: Strategic partnerships with other pharmaceutical companies for development, commercialization, or research boost investor sentiment. Deal terms and potential revenue sharing influence the degree of impact.

Competition: The competitive landscape, particularly from established therapies or biosimilars, affects market share and pricing power. Increased competition can put downward pressure on the stock.

Market Conditions: Overall market sentiment, especially within the biotechnology and pharmaceutical sectors, influences investor appetite for MGNX.US. Economic downturns or sector-specific concerns can lead to broader sell-offs.

Financial Performance: Revenue, profitability, cash flow, and debt levels impact investor perception of the company's financial health. Strong financials generally support a higher stock price, while weaknesses can negatively impact it.

Acquisition Rumors: Speculation about a potential acquisition of MacroGenics often causes stock price volatility. Actual acquisition offers typically result in a price surge.

Management Guidance: Management's outlook for future performance, communicated through earnings calls and investor presentations, shapes investor expectations. Positive guidance can boost the stock, while negative guidance can depress it.

Patent Protection: The strength and duration of patent protection for key drugs like Margenza are crucial for maintaining market exclusivity. Patent challenges or expirations can negatively affect future revenue streams and stock price.

General Economic Conditions: Broader economic factors such as interest rates, inflation, and GDP growth can influence investor sentiment and the overall stock market, indirectly affecting MGNX.US.

Analyst Ratings: Upgrades or downgrades from financial analysts can influence investor perception and trading activity. Positive ratings can attract buyers, while negative ratings can trigger selling pressure.

News and Media Coverage: Significant positive or negative news coverage about the company, its products, or the industry can affect investor sentiment and trading volume.

People Also Watch

Latest news

US Steel and Aluminum Tariffs Revamped: Simplification Amidst Potential Cost Increases

Noah Lee|--

SpaceX Files Secret IPO Bid, Eyeing Record-Breaking $1.75 Trillion Valuation

Ava Grace|--

US Intelligence: Iran Unwilling to Engage in Substantive Talks to End War

Sophia Claire|--

Latest Education Articles

What Is Sensex in Stock Market: Meaning, Calculation, and Why It Matters for Investors

What Is Sensex in Stock Market: Meaning, Calculation, and Why It Matters for Investors

Ghko B|--
Investing basics for beginners: What are the 4 economic indicators?

Investing basics for beginners: What are the 4 economic indicators?

Frances Wang|--
CFDs vs Options: What’s the Difference?

CFDs vs Options: What’s the Difference?

Julian Parker|--